EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Strategic Focus

Strategic Focus

Partnering is a key element in delivering meaningful therapies to patients with unmet medical needs.
Our goal is to craft a pipeline that is well balanced with a mix of both internal and externally-sourced assets that are in line with the company’s growth goals and strategically fit with both commercial and developmental strengths.
We consider all opportunities that have the potential to create value using innovative deal structures and creative alliances.
We are particularly interested in opportunities that will support our strategic business objectives:

Strengthen our pipeline

  • With novel, innovative ideas and projects
  • Truly portfolio-transforming assets
  • Building on innovative and emerging technologies
Strengthen our key franchises

  • Oncology
  • Immuno-­Oncology
  • Immunology
  • Multiple Sclerosis
  • Fertility
Strengthen our geographic presence

  • Grow our U.S. business with specialist­-focused therapies
  • Expand our ongoing presence in the Japanese market
  • Capitalize on our strong presence in growing markets
Send us your proposal
Every proposal is considered by our team, which is committed to bringing innovative products to the market.
Reviewers include scientific and clinical experts in your specific field of endeavor, as well as members of our business development team.
Share your opportunity by email, and your business proposition will be quickly reviewed. You will receive a rapid electronic response.
Send your proposal to partnering@emdserono.com or directly to one of our contacts.


For us, collaborations are important to source for new compounds, and to gain access to the latest technology platforms, that complement our company's own R&D efforts to develop novel therapeutics for patients.

Independent from our therapeutic areas of focus, we are consciously agnostic of the source of assets that can enrich our global commercial and regional portfolio. The focus is first and foremost on the quality and potential benefit these assets can bring to patients.